The Discounted Cash Flow (DCF) valuation of ImmunoGen Inc (IMGN) is (43.23) USD. With the latest stock price at 31.23 USD, the upside of ImmunoGen Inc based on DCF is -238.4%.
Based on the latest price of 31.23 USD and our DCF valuation, ImmunoGen Inc (IMGN) is a sell. selling IMGN stocks now will result in a potential gain of 238.4%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.7% - 8.9% | 7.3% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (204.34) - (24.00) | (43.23) |
| Upside | -754.3% - -176.8% | -238.4% |